Friday, February 10, 2012
Top research highlighted in fight against heart disease and stroke
American Heart Association/American Stroke Association 2011 Top Research Reports February 06, 2012 FOR IMMEDIATE RELEASE DALLAS, February 6, 2012 – The American Heart Association/American Stroke Association has been compiling an annual list of the major advances in heart disease and stroke research since 1996. This year, the association again compiled two separate lists – one with a focus on overall cardiovascular health, the other with a focus on research related to strokes. Areas of advancement noted this year include lifestyle risk prevention, congenital heart disease, genetics/personalized medicine, new drugs and treatment in the battle against atrial fibrillation, improved systems of care to deliver faster care for heart attack and stroke among others. More than 40 scientific studies were highlighted in the report. View full list: Top Advanced in Cardiovascular Disease and Stroke Research 2011. ### The American Heart Association/American Stroke Association receives funding mostly from individuals. Foundations and corporations donate as well, and fund specific programs and events. Strict policies are enforced to prevent these relationships from influencing the association’s science content. Financial information for the American Heart Association, including a list of contributions from pharmaceutical companies and device manufacturers, is available at www.heart.org/corporatefunding. NR12-1027 (Top Research 2011) For Media Inquiries: (214) 706-1173For Public Inquiries: (800) AHA-USA1 Tweet Newsroom Home Browse News Releases Browse Multimedia Audio Images Podcasts Video & Animations Usage Policy News Media Media Contacts Access to AHA/ASA Embargoed Media Materials Boilerplate Branding Guidelines Copyright Permissions Embargo Policy Linking Policy Public Service Announcements Frequently Requested Resources About Us Heart and Stroke Encyclopedia Medical Illustration Library (For viewing only
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment